Responses to dupilumab (Dupixent) treatment were consistent across racial and ethnic groups in children with atopic ...

AD is a growing market with an impressive pipeline of new products from current and future players in the field.

Using a topical steroid on your face is a common one, but perioral dermatitis can also show up if you’re using thick or oily ...

Atopic dermatitis, asthma, and allergic rhinitis are among the allergic diseases tied to a significantly increased risk for ...

Significant research has documented the impact of atopic dermatitis on mental health. Not only does stress trigger eczema ...

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar.

A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...

Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ex-Dermira executives.

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

All of those issues can be signs of perioral dermatitis, a common skin condition that appears as a rash around your mouth, nose, and sometimes near your eyes. Here comes the rough part ...

With the recent developments in the atopic dermatitis (AD) market, the field is becoming more competitive as novel therapies are soon anticipated to enter the market. This evolution may benefit AD ...